BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ferro D, Celestini A, Violi F. Hyperfibrinolysis in liver disease. Clin Liver Dis 2009;13:21-31. [PMID: 19150306 DOI: 10.1016/j.cld.2008.09.008] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Webster CR. Hemostatic Disorders Associated with Hepatobiliary Disease. Veterinary Clinics of North America: Small Animal Practice 2017;47:601-15. [DOI: 10.1016/j.cvsm.2016.11.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
2 Tischer S, Miller JT. Pharmacologic Strategies to Prevent Blood Loss and Transfusion in Orthotopic Liver Transplantation. Critical Care Nursing Quarterly 2016;39:267-80. [DOI: 10.1097/cnq.0000000000000120] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
3 Abuelkasem E, Lu S, Tanaka K, Planinsic R, Sakai T. Comparison between thrombelastography and thromboelastometry in hyperfibrinolysis detection during adult liver transplantation. British Journal of Anaesthesia 2016;116:507-12. [DOI: 10.1093/bja/aew023] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 9.7] [Reference Citation Analysis]
4 Rijken DC, Kock EL, Guimarães AH, Talens S, Darwish Murad S, Janssen HL, Leebeek FW. Evidence for an enhanced fibrinolytic capacity in cirrhosis as measured with two different global fibrinolysis tests. J Thromb Haemost 2012;10:2116-22. [PMID: 22906184 DOI: 10.1111/j.1538-7836.2012.04901.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 44] [Article Influence: 6.4] [Reference Citation Analysis]
5 Kozek-langenecker SA, Afshari A, Albaladejo P, Santullano CAA, De Robertis E, Filipescu DC, Fries D, Görlinger K, Haas T, Imberger G, Jacob M, Lancé M, Llau J, Mallett S, Meier J, Rahe-meyer N, Samama CM, Smith A, Solomon C, Van der Linden P, Wikkelsø AJ, Wouters P, Wyffels P. Management of severe perioperative bleeding: Guidelines from the European Society of Anaesthesiology. European Journal of Anaesthesiology 2013;30:270-382. [DOI: 10.1097/eja.0b013e32835f4d5b] [Cited by in Crossref: 553] [Cited by in F6Publishing: 133] [Article Influence: 61.4] [Reference Citation Analysis]
6 Schofield N, Sugavanam A, Thompson K, Mallett SV. No increase in blood transfusions during liver transplantation since the withdrawal of aprotinin. Liver Transpl. 2014;20:584-590. [PMID: 24481770 DOI: 10.1002/lt.23839] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
7 Tripodi A, Primignani M, Mannucci PM, Caldwell SH. Changing Concepts of Cirrhotic Coagulopathy. Am J Gastroenterol. 2017;112:274-281. [PMID: 27801884 DOI: 10.1038/ajg.2016.498] [Cited by in Crossref: 90] [Cited by in F6Publishing: 71] [Article Influence: 15.0] [Reference Citation Analysis]
8 Jairath V, Desborough MJR. Modern-day management of upper gastrointestinal haemorrhage: Managing upper gastrointestinal haemorrhage. Transfusion Med 2015;25:351-7. [DOI: 10.1111/tme.12266] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ng VL. Liver disease, coagulation testing, and hemostasis. Clin Lab Med. 2009;29:265-282. [PMID: 19665678 DOI: 10.1016/j.cll.2009.05.001] [Cited by in Crossref: 32] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
10 Trzebicki J, Kosieradzki M, Flakiewicz E, Kuzminska G, Wasiak D, Pacholczyk M, Lagiewska B, Lisik W, Kosson D, Kulik A. Detrimental effect of aprotinin ban on amount of blood loss during liver transplantation: single-center experience. Transplant Proc. 2011;43:1725-1727. [PMID: 21693266 DOI: 10.1016/j.transproceed.2011.01.182] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
11 Magnusson M, Ignjatovic V, Hardikar W, Monagle P. A conceptual and practical approach to haemostasis in paediatric liver disease. Arch Dis Child. 2016;101:854-859. [PMID: 27013527 DOI: 10.1136/archdischild-2015-309535] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
12 Fry W, Lester C, Etedali NM, Shaw S, DeLaforcade A, Webster CR. Thromboelastography in Dogs with Chronic Hepatopathies. J Vet Intern Med 2017;31:419-26. [PMID: 28097681 DOI: 10.1111/jvim.14639] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
13 Roullet S, Labrouche S, Freyburger G. Fibrinolysis during liver transplantation: analysis by the Thrombodynamics method. J Clin Pathol 2019;72:636-8. [PMID: 30975704 DOI: 10.1136/jclinpath-2018-205560] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
14 Jones JM, Bhutiani N, Wei D, Goldstein L, Jones CM, Cannon RM. A literature-based cost analysis of tissue plasminogen activator for prevention of biliary stricture in donation after circulatory death liver transplantation. Am J Surg 2018;216:959-62. [PMID: 29724406 DOI: 10.1016/j.amjsurg.2018.04.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Flores B, Trivedi HD, Robson SC, Bonder A. Hemostasis, bleeding and thrombosis in liver disease. J Transl Sci 2017;3. [PMID: 30221012 DOI: 10.15761/JTS.1000182] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 2.6] [Reference Citation Analysis]
16 DeAngelis GA, Khot R, Haskal ZJ, Maitland HS, Northup PG, Shah NL, Caldwell SH. Bleeding Risk and Management in Interventional Procedures in Chronic Liver Disease. J Vasc Interv Radiol 2016;27:1665-74. [PMID: 27595469 DOI: 10.1016/j.jvir.2016.05.039] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
17 Forkin KT, Colquhoun DA, Nemergut EC, Huffmyer JL. The Coagulation Profile of End-Stage Liver Disease and Considerations for Intraoperative Management. Anesth Analg 2018;126:46-61. [PMID: 28795966 DOI: 10.1213/ANE.0000000000002394] [Cited by in Crossref: 32] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
18 Maruyama H, Okugawa H, Takahashi M, Yokosuka O. De novo portal vein thrombosis in virus-related cirrhosis: predictive factors and long-term outcomes. Am J Gastroenterol. 2013;108:568-574. [PMID: 23381015 DOI: 10.1038/ajg.2012.452] [Cited by in Crossref: 121] [Cited by in F6Publishing: 109] [Article Influence: 13.4] [Reference Citation Analysis]
19 Stotts MJ, Davis JPE, Shah NL. Coagulation testing and management in liver disease patients. Curr Opin Gastroenterol 2020;36:169-76. [PMID: 32141899 DOI: 10.1097/MOG.0000000000000635] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Mangus RS, Kinsella SB, Fridell JA, Kubal CA, Lahsaei P, Mark LO, Tector AJ. Aminocaproic Acid (amicar) as an alternative to aprotinin (trasylol) in liver transplantation. Transplant Proc 2014;46:1393-9. [PMID: 24935303 DOI: 10.1016/j.transproceed.2014.04.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
21 Weingarten MA, Sande AA. Acute liver failure in dogs and cats. J Vet Emerg Crit Care (San Antonio) 2015;25:455-73. [PMID: 25882813 DOI: 10.1111/vec.12304] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.9] [Reference Citation Analysis]
22 Kodali S, Holmes CE, Tipirneni E, Cahill CR, Goodwin AJ, Cushman M. Successful management of refractory bleeding in liver failure with tranexamic acid: Case report and literature review. Res Pract Thromb Haemost 2019;3:424-8. [PMID: 31294331 DOI: 10.1002/rth2.12203] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
23 Kleinegris MC, Bos MH, Roest M, Henskens Y, Ten Cate-Hoek A, Van Deursen C, Spronk HM, Reitsma PH, De Groot PG, Ten Cate H. Cirrhosis patients have a coagulopathy that is associated with decreased clot formation capacity. J Thromb Haemost. 2014;12:1647-1657. [PMID: 25142532 DOI: 10.1111/jth.12706] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 5.6] [Reference Citation Analysis]
24 Mannucci PM, Tripodi A. Liver disease, coagulopathies and transfusion therapy. Blood Transfus. 2013;11:32-36. [PMID: 23058863 DOI: 10.2450/2012.0151-12] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
25 Amarapurkar PD, Amarapurkar DN. Management of coagulopathy in patients with decompensated liver cirrhosis. Int J Hepatol 2011;2011:695470. [PMID: 22164337 DOI: 10.4061/2011/695470] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Kelley D, Lester C, Shaw S, de Laforcade A, Webster CR. Thromboelastographic Evaluation of Dogs with Acute Liver Disease. J Vet Intern Med 2015;29:1053-62. [PMID: 26179169 DOI: 10.1111/jvim.13441] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
27 Langhorn R, Poulsen MK, Heidemann PL, Bochsen L, Ritz C, Kristensen AT, Nielsen LN. Diagnosis of primary hyperfibrinolysis and in vitro investigation of the inhibitory effects of tranexamic acid in a group of dogs with sarcomas - A pilot study. Res Vet Sci 2021;136:472-7. [PMID: 33838456 DOI: 10.1016/j.rvsc.2021.03.028] [Reference Citation Analysis]
28 Lin YT, Cheng YK, Lin CL, Wang IK. Increased risk of subdural hematoma in patients with liver cirrhosis. QJM 2017;110:815-20. [PMID: 29025006 DOI: 10.1093/qjmed/hcx167] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
29 Gologorsky E, Andrews DM, Gologorsky A, Sampathi V, Sundararaman L, Govindaswamy R, Raveh Y, Tzakis AG, Pretto EA. Devastating intracardiac and aortic thrombosis: a case report of apparent catastrophic antiphospholipid syndrome during liver transplantation. Journal of Clinical Anesthesia 2011;23:398-402. [DOI: 10.1016/j.jclinane.2010.07.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
30 Kavanagh C, Shaw S, Webster CR. Coagulation in hepatobiliary disease. J Vet Emerg Crit Care (San Antonio). 2011;21:589-604. [PMID: 22316251 DOI: 10.1111/j.1476-4431.2011.00691.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
31 Arshad F, Ickx B, van Beem RT, Polak W, Grüne F, Nevens F, Ilmakunnas M, Koivusalo AM, Isoniemi H, Strengers PF. Prothrombin complex concentrate in the reduction of blood loss during orthotopic liver transplantation: PROTON-trial. BMC Surg. 2013;13:22. [PMID: 23815798 DOI: 10.1186/1471-2482-13-22] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 5.6] [Reference Citation Analysis]
32 Parker A, Karvellas CJ. Coagulation Defects in the Cirrhotic Patient Undergoing Liver Transplantation. Transplantation 2018;102:1453-8. [DOI: 10.1097/tp.0000000000002273] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
33 Charpentier V, Ives ST. Hyperfibrinolysis: An Uncommon Cause of Bleeding in Cirrhosis. Am J Med 2022;135:53-4. [PMID: 34343519 DOI: 10.1016/j.amjmed.2021.06.045] [Reference Citation Analysis]
34 Muciño-bermejo J, Carrillo-esper R, Uribe M, Méndez-sánchez N. Coagulation abnormalities in the cirrhotic patient. Annals of Hepatology 2013;12:713-24. [DOI: 10.1016/s1665-2681(19)31312-2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 1] [Article Influence: 3.9] [Reference Citation Analysis]
35 Ke Z, Hao X, Ning W, Zu MH, Fun YF. Fibrinolysis status in the Budd-Chiari syndrome in China. Blood Coagul Fibrinolysis 2015;26:721-6. [PMID: 24911452 DOI: 10.1097/MBC.0000000000000143] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
36 Minemura M, Tajiri K, Shimizu Y. Systemic abnormalities in liver disease. World J Gastroenterol 2009; 15(24): 2960-2974 [PMID: 19554648 DOI: 10.3748/wjg.15.2960] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
37 Amarapurkar PD, Amarapurkar DN. Management of coagulopathy in patients with decompensated liver cirrhosis. Int J Hepatol. 2011;2011:695470. [PMID: 22164337 DOI: 10.4061/2011/695470] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
38 Pluta A, Gutkowski K, Hartleb M. Coagulopathy in liver diseases. Adv Med Sci. 2010;55:16-21. [PMID: 20513645 DOI: 10.2478/v10039-010-0018-3] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
39 Roullet S, Freyburger G, Labrouche S, Morisse E, Stecken L, Quinart A, Laurent C, Sztark F. Hyperfibrinolysis during liver transplantation is associated with bleeding. Thromb Haemost 2015;113:1145-8. [PMID: 25693891 DOI: 10.1160/TH14-08-0655] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
40 Roullet S, Labrouche S, Mouton C, Quinart A, Nouette-gaulain K, Laurent C, Freyburger G. Lysis Timer: a new sensitive tool to diagnose hyperfibrinolysis in liver transplantation. J Clin Pathol 2018;72:58-65. [DOI: 10.1136/jclinpath-2018-205280] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
41 Mannucci PM, Tripodi A. Hemostatic defects in liver and renal dysfunction. Hematology 2012;2012:168-73. [DOI: 10.1182/asheducation.v2012.1.168.3798232] [Cited by in Crossref: 32] [Article Influence: 3.2] [Reference Citation Analysis]
42 Intagliata NM, Argo CK, Stine JG, Lisman T, Caldwell SH, Violi F; faculty of the 7th International Coagulation in Liver Disease. Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease: Proceedings of the 7th International Coagulation in Liver Disease Conference. Thromb Haemost. 2018;118:1491-1506. [PMID: 30060258 DOI: 10.1055/s-0038-1666861] [Cited by in Crossref: 69] [Cited by in F6Publishing: 66] [Article Influence: 17.3] [Reference Citation Analysis]
43 Shah NL, Banaei YP, Hojnowski KL, Cornella SL. Management options in decompensated cirrhosis. Hepat Med 2015;7:43-50. [PMID: 26203291 DOI: 10.2147/HMER.S62463] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
44 Theusinger OM, Wanner GA, Emmert MY, Billeter A, Eismon J, Seifert B, Simmen HP, Spahn DR, Baulig W. Hyperfibrinolysis diagnosed by rotational thromboelastometry (ROTEM) is associated with higher mortality in patients with severe trauma. Anesth Analg 2011;113:1003-12. [PMID: 21918164 DOI: 10.1213/ANE.0b013e31822e183f] [Cited by in Crossref: 131] [Cited by in F6Publishing: 35] [Article Influence: 11.9] [Reference Citation Analysis]